Cantor Fitzgerald reiterates Quince Therapeutics stock Overweight rating

Markets Investing.com By Investing.com 25 Jun 2026 12:21 1 min read

Cantor Fitzgerald reiterates Quince Therapeutics stock Overweight rating

Cantor Fitzgerald reiterates Quince Therapeutics stock Overweight rating

Cantor Fitzgerald reiterates Quince Therapeutics stock Overweight rating

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.